FFA
AMLX icon

Farther Finance Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History

Farther Finance Advisors’s Portfolio AMLX Stock Details AMLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.2K Buy
316
+57
+22% +$1.51K ﹤0.01% 4669
2026
Q2 		$4.65K Buy
259
+237
+1,077% +$3.67K ﹤0.01% 4838
2026
Q1 		$316 Buy
22
+2
+10% +$28 ﹤0.01% 5362
2025
Q4 		$242 Hold
20
– – ﹤0.01% 5184
2025
Q3 		$272 Buy
+20
New +$188 ﹤0.01% 4661
2024
Q1 		– Sell
-27
Closed -$397 – 3591
2023
Q4 		$397 Buy
+27
New +$414 ﹤0.01% 3048

Other funds holding AMLX

VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 19.15% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's AMLX Position: Q3 2026 in Review

Farther Finance Advisors increased its Amylyx Pharmaceuticals (AMLX) stake by 22% in Q3 2026, buying an estimated $1.51K and bringing the position to 316 shares worth $9.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4669.

Farther Finance Advisors first reported a position in AMLX in Q4 2023 and has held it in 6 quarters since. 6 funds tracked by Wall St. Rank hold AMLX as of Q3 2026.

  • Farther Finance Advisors held 316 shares of Amylyx Pharmaceuticals worth $9.2K as of Q3 2026.
  • Farther Finance Advisors bought 57 Amylyx Pharmaceuticals shares in Q3 2026, an estimated $1.51K.
  • Amylyx Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #4669 holding.
  • Farther Finance Advisors first reported a position in Amylyx Pharmaceuticals in Q4 2023 and has held it in 6 quarters since.
  • 6 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.